Entera Bio Ltd. · NASDAQ:ENTX
Burshtein Gregory received 87,591 Entera Bio Ltd. shares as an award (Form 4)
Traded May 7, 2026 · Filed May 8, 2026
On May 7, 2026, Burshtein Gregory (Chief of R&D) received 87,591 Entera Bio Ltd. shares as an award, leaving 189,033 shares. Filed May 8, 2026 (Form 4).
- Awarded
- 87,591 shares
- Holding after
- 189,033 shares
- Trading plan
- No
- Role
- Chief of R&D
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 7, 2026 | Ordinary Shares, par value NIS 0.0000769 per share | Award | 87,591 | 189,033 | Direct |